Dr. Lipton is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
500 University Dr
Hershey, PA 17033Phone+1 800-233-4082
Education & Training
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1967 - 1969
NYU Grossman School of MedicineResidency, Internal Medicine, 1964 - 1965- NYU Grossman School of MedicineInternship, Transitional Year, 1963 - 1964
- New York University School of MedicineClass of 1963
Certifications & Licensure
PA State Medical License 1971 - 2022
OR State Medical License 2011 - 2015
MA State Medical License 1980 - 2013- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Single Dosing of Zoledronic Acid in Cancer Therapy Induced Bone Loss (CTIBL) Start of enrollment: 2005 Sep 01
- Trial of RAD001 in Triple Negative Metastatic Breast Cancer Start of enrollment: 2009 Apr 01
Publications & Presentations
PubMed
- 238 citationsElevated serum c-erbB-2 antigen levels and decreased response to hormone therapy of breast cancer.Kim Leitzel, Yoshio Teramoto, Kristine Konrad, Vernon M. Chinchilli, Gena H. Volas
Journal of Clinical Oncology. 1995-05-01 - 39 citationsMetastatic breast cancer: overview of treatment.Suhail M. Ali, Harold A. Harvey, Allan Lipton
Clinical Orthopaedics and Related Research. 2003-10-01 - 67 citationsRandomized Trial of Aminoglutethimide versus Tamoxifen in Metastatic Breast CancerAllan Lipton, Harold A. Harvey, Richard J. Santen, A. E. Boucher, Deborah L. White
Cancer Research. 1982-08-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
